Aside from a home, for most people, a motor vehicle is the largest purchase they will ever make. Consumers who purchase a motor vehicle have the right to expect that a vehicle and all of its components have undergone and passed extensive safety tests and inspections. Despite this reasonable expectation which is fortified and enforced by consumer protection laws, in recent years, the number of recalls involving dangerous and defective motor vehicle parts has skyrocketed.
Drug makers are required to list potential side effects on labels and take the necessary and reasonable steps to ensure that prescribing doctors are aware of any risks to patients. Unfortunately, a mistake at any point, whether in the testing, packaging or taking a drug to market, can have a negative impact on consumers, who may then have to sue the drug company for product liability.
Legal complaints continue to be filed in connection with defective ignition switches made by General Motors. The defective switches can cause cars to shut down suddenly, and 45 fatalities have been linked to the defects. The company has recalled about 2.6 million affected vehicles. Now, in addition to legal claims brought by families of the deceased, a class action lawsuit has been filed by GM investors.
Class action lawsuits relate to a specific area of law, and many people are not aware of how class actions work. Here let's go over the basics.
Honda Motor Co. and Takata Corp. are the targets of a recently filed lawsuit alleging the manufacturers prioritized profits over customer safety. The suit, which seeks class-action status, claims that Takata built cheap airbags to cut costs and that Honda bought the airbags to cut manufacturing expenses. Consequently, the airbags are "killing and maiming drivers and passengers involved in otherwise minor and survivable accidents."
People generally assume that products available to consumers are reasonably safe when used in the proper manner. However, the reality is that each year many products have to be recalled because they pose an unreasonable risk of injury or death, even if the products were initially approved by government regulators.